Login / Signup

The use of azithromycin and pyrimethamine for treatment of cerebral toxoplasmosis in human immunodeficiency virus-infected patients: a systematic review.

Mark Erving H RamosSteven G Villaraza
Published in: Encephalitis (Seoul, Korea) (2023)
The combination therapy of azithromycin and pyrimethamine is less effective than the standard treatment regimen for maintenance therapy for cerebral toxoplasmosis; thus, administering these medications for this indication must be met with caution.
Keyphrases
  • combination therapy
  • human immunodeficiency virus
  • hepatitis c virus
  • subarachnoid hemorrhage
  • hiv infected
  • tyrosine kinase
  • cerebral ischemia
  • blood brain barrier